Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Design Of Experiment Approach In Development Of Febuxostat Nanocrystal: Application Of Soluplus® As Stabilizer

O. P. Sharma, Viral Patel, T. Mehta
Published 2016 · Materials Science

Save to my Library
Download PDF
Analyze on Scholarcy
Abstract The objective of present study was to explore the application of Soluplus® as a stabilizer for the preparation of febuxostat (FEB) nanocrystals using ball milling technique. Preliminary trials were performed for the selection of stabilizer from HPMC VLV, PVA, PVP K30, Poloxamer 188 and Soluplus®. Soluplus® stabilized FEB nanocrystals were found stable and had least particle size as compared to the batches prepared using other stabilizers. A systematic optimization of critical process parameters, stirring time and amount of bead, of ball milling process was performed with aid of central composite design. Particle size (D50 and D90) and the size distribution (SPAN) were taken as responses for the evaluation of design batches and were used as the criteria for selection of optimized batch. Optimized formulation was characterized using SEM, XRD and DSC, depicted conversion of crystalline FEB into amorphous form having 26.08 times (in pH 1.2) and 1.67 times (in pH 6.0) more saturation solubility. In vitro drug dissolution study showed 9 times faster drug release while in vivo pharmacokinetic study showed an increase in oral bioavailability, Cmax and AUC, of FEB nanocrystals as compared to FEB API. Thus, current study supports the suitability of Soluplus® as stabilizer for the preparation of FEB nanocrystals.
This paper references
The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human.
Y. Wu (2004)
Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation
T. Jiang (2012)
Investigation of a nanosuspension stabilized by Soluplus® to improve bioavailability.
Hua Yang (2014)
Febuxostat: a selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout.
M. Ernst (2009)
Formulation and Antitumor Activity Evaluation of Nanocrystalline Suspensions of Poorly Soluble Anticancer Drugs
E. Merisko-Liversidge (2004)
Effects of particle size on the pharmacokinetics of puerarin nanocrystals and microcrystals after oral administration to rat.
Liangxing Tu (2013)
Design and evaluation of injectable niclosamide nanocrystals prepared by wet media milling technique
Yanghuan Ye (2015)
Amorphous formulations for dissolution and bioavailability enhancement of poorly soluble APIs
P. Kanaujia (2015)
Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods
L. Peltonen (2010)
Optimization of formulation and process parameters for the production of nanosuspension by wet media milling technique: effect of Vitamin E TPGS and nanocrystal particle size on oral absorption.
Indrajit K. Ghosh (2012)
Impact of process parameters on the breakage kinetics of poorly water-soluble drugs during wet stirred media milling: a microhydrodynamic view.
A. Afolabi (2014)
Soluble Cocrystals of the Xanthine Oxidase Inhibitor Febuxostat
D. Maddileti (2013)
Stability of nanosuspensions in drug delivery.
Y. Wang (2013)
Formulation and Evaluation of Poorly Soluble Febuxostat Orodispersable Tablet
K. K. Kumar (2014)
Nanocrystal technology, drug delivery and clinical applications
Jens-Uwe A. H. Junghanns (2008)
Formulation optimization of gastroretentive drug delivery system for allopurinol using experimental design
O. P. Sharma (2015)
Liquid antisolvent precipitation and stabilization of nanoparticles of poorly water soluble drugs in aqueous suspensions: Recent developments and future perspective
Alpana Ankush Thorat (2012)
Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo.
M. Linn (2012)
Formulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspension.
Bhupesh K Ahuja (2015)
Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs.
Jun-ichi Jinno (2006)
Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs
V. Junyaprasert (2015)
Nanoparticle Engineering Processes for Enhancing the Dissolution Rates of Poorly Water Soluble Drugs
Jiahui Hu (2004)
Preparation and Characterization of an Oridonin Nanosuspension for Solubility and Dissolution Velocity Enhancement
L. Gao (2007)
Scanning probe microscopy method for nanosuspension stabilizer selection.
S. Verma (2009)
Design of experiment approach for formulating multi-unit colon-targeted drug delivery system: in vitro and in vivo studies
N. Shah (2016)
Soluplus®: A novel polymeric solubilizer for optimization of Carvedilol solid dispersions: Formulation design and effect of method of preparation
R. Shamma (2013)
Solid formulations by a nanocrystal approach: critical process parameters regarding scale-ability of nanocrystals for tableting applications.
A. Tuomela (2015)
Effect of food or antacid on pharmacokinetics and pharmacodynamics of febuxostat in healthy subjects.
R. Khosravan (2008)
Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation
G. V. Patel (2014)
Solubility and dissolution enhancement strategies: current understanding and recent trends*
S. Jain (2015)
Preparation and pharmacodynamic assessment of ezetimibe nanocrystals: Effect of P-gp inhibitory stabilizer on particle size and oral absorption.
K. Srivalli (2015)
Design and development of solid nanoparticulate dosage forms of telmisartan for bioavailability enhancement by integration of experimental design and principal component analysis
J. Patel (2014)

This paper is referenced by
Application and Functional Characterization of Kollicoat Smartseal 30D as a Solid Dispersion Carrier for Improving Solubility
Chivate Amit (2020)
Enhanced oral bioavailability and diminished food effect of lurasidone hydrochloride nanosuspensions prepared by facile nanoprecipitation based on dilution
P. Yu (2017)
Optimization and evaluation of cyclosporine A nanosuspension stabilized by combination stabilizers using high pressure homogenization method
Sıla Gülbağ Pinar (2019)
Emerging role of nanosuspensions in drug delivery systems
Shery Jacob (2020)
Febuxostat-Minoxidil Salt Solvates: Crystal Structures, Characterization, Interconversion and Solubility Performance
Li-Yang Li (2018)
Enhancement of in vitro dissolution and in vivo performance/oral absorption of FEB-poloxamer-TPGS solid dispersion
X. Sheng (2018)
Significant solubility of carbon dioxide in Soluplus® facilitates impregnation of ibuprofen using supercritical fluid technology
R. Obaidat (2018)
A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes
Pooja J Patel (2018)
Nanocrystal: a novel approach to overcome skin barriers for improved topical drug delivery
V. Patel (2018)
Hybridized Nanoamorphous Micellar Dispersion Using a QbD-DM3 Linked Rational Product Design Strategy for Ritonavir: a BCS IV Drug.
V. Rathod (2020)
Studies on the curcumin phospholipid complex solidified with Soluplus®
Jianan Wang (2018)
Enhanced Physical Stability and Synchronized Release of Febuxostat and Indomethacin in Coamorphous Solids
Sakib M. Moinuddin (2020)
Preparation, optimisation, and in vitro–in vivo evaluation of febuxostat ternary solid dispersion
Jingjing Tang (2018)
Impact of Process Parameters on Particle Size Involved in Media Milling Technique Used for Preparing Clotrimazole Nanocrystals for the Management of Cutaneous Candidiasis
V. Patel (2019)
Nanocrystals of Novel Valerolactam-Fenbendazole Hybrid with Improved in vitro Dissolution Performance
Maria Elisa Melian (2020)
Mechanistic Modeling of Wet Stirred Media Milling for Production of Drug Nanosuspensions.
E. Bilgili (2020)
Semantic Scholar Logo Some data provided by SemanticScholar